Rodgers Brothers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.7M | Buy |
127,462
+490
| +0.4% | +$109K | 3.2% | 3 |
|
|
2025
Q4 | $29M | Sell |
126,972
-2,134
| -2% | -$486K | 3.47% | 3 |
|
|
2025
Q3 | $29.9M | Sell |
129,106
-2,350
| -2% | -$479K | 3.68% | 3 |
|
|
2025
Q2 | $24.4M | Sell |
131,456
-668
| -0.5% | -$124K | 3.08% | 3 |
|
|
2025
Q1 | $27.7M | Sell |
132,124
-425
| -0.3% | -$82.6K | 3.69% | 3 |
|
|
2024
Q4 | $23.6M | Sell |
132,549
-675
| -0.5% | -$124K | 3.07% | 4 |
|
|
2024
Q3 | $26.3M | Sell |
133,224
-361
| -0.3% | -$67.4K | 3.34% | 3 |
|
|
2024
Q2 | $22.9M | Sell |
133,585
-578
| -0.4% | -$95.7K | 3.1% | 3 |
|
|
2024
Q1 | $24.4M | Buy |
134,163
+4,816
| +4% | +$830K | 3.33% | 2 |
|
|
2023
Q4 | $20M | Sell |
129,347
-4,875
| -4% | -$711K | 3.16% | 3 |
|
|
2023
Q3 | $20M | Buy |
134,222
+5,275
| +4% | +$774K | 3.42% | 2 |
|
|
2023
Q2 | $17.4M | Buy |
128,947
+5,839
| +5% | +$856K | 3.06% | 4 |
|
|
2023
Q1 | $19.6M | Buy |
123,108
+906
| +0.7% | +$139K | 3.77% | 2 |
|
|
2022
Q4 | $19.7M | Sell |
122,202
-293
| -0.2% | -$44.9K | 3.97% | 2 |
|
|
2022
Q3 | $16.4M | Sell |
122,495
-487
| -0.4% | -$69.9K | 3.5% | 2 |
|
|
2022
Q2 | $18.8M | Sell |
122,982
-577
| -0.5% | -$88.2K | 3.72% | 2 |
|
|
2022
Q1 | $20M | Sell |
123,559
-1,067
| -0.9% | -$155K | 3.6% | 3 |
|
|
2021
Q4 | $16.9M | Sell |
124,626
-25
| -0% | -$2.95K | 3% | 5 |
|
|
2021
Q3 | $13.4M | Sell |
124,651
-12,615
| -9% | -$1.44M | 2.68% | 5 |
|
|
2021
Q2 | $15.5M | Sell |
137,266
-1,107
| -0.8% | -$125K | 2.96% | 3 |
|
|
2021
Q1 | $15M | Buy |
138,373
+2,830
| +2% | +$303K | 3.1% | 4 |
|
|
2020
Q4 | $14.5M | Buy |
135,543
+5,056
| +4% | +$486K | 3.32% | 2 |
|
|
2020
Q3 | $11.4M | Sell |
130,487
-147
| -0.1% | -$13.8K | 2.96% | 5 |
|
|
2020
Q2 | $12.8M | Sell |
130,634
-1,173
| -0.9% | -$103K | 3.48% | 3 |
|
|
2020
Q1 | $10M | Buy |
131,807
+1,342
| +1% | +$114K | 3.19% | 4 |
|
|
2019
Q4 | $11.6M | Sell |
130,465
-1,496
| -1% | -$124K | 3% | 4 |
|
|
2019
Q3 | $9.99M | Buy |
131,961
+2,128
| +2% | +$146K | 2.77% | 5 |
|
|
2019
Q2 | $9.44M | Buy |
129,833
+16,578
| +15% | +$1.3M | 2.62% | 5 |
|
|
2019
Q1 | $9.13M | Buy |
113,255
+8,609
| +8% | +$704K | 2.6% | 5 |
|
|
2018
Q4 | $9.65M | Sell |
104,646
-1,499
| -1% | -$132K | 3.1% | 4 |
|
|
2018
Q3 | $10M | Sell |
106,145
-552
| -0.5% | -$52.3K | 2.88% | 2 |
|
|
2018
Q2 | $9.88M | Buy |
106,697
+6,374
| +6% | +$623K | 3.02% | 2 |
|
|
2018
Q1 | $9.5M | Sell |
100,323
-393
| -0.4% | -$43.2K | 3.1% | 2 |
|
|
2017
Q4 | $9.74M | Sell |
100,716
-721
| -0.7% | -$68K | 3.18% | 2 |
|
|
2017
Q3 | $9.01M | Sell |
101,437
-9,168
| -8% | -$698K | 3.17% | 2 |
|
|
2017
Q2 | $8.02M | Buy |
110,605
+295
| +0.3% | +$19.8K | 2.96% | 4 |
|
|
2017
Q1 | $7.19M | Buy |
110,310
+3
| +0% | +$189 | 2.71% | 5 |
|
|
2016
Q4 | $6.91M | Sell |
110,307
-249
| -0.2% | -$15.2K | 2.71% | 5 |
|
|
2016
Q3 | $6.97M | Buy |
110,556
+479
| +0.4% | +$31K | 2.8% | 4 |
|
|
2016
Q2 | $6.82M | Buy |
110,077
+3,889
| +4% | +$237K | 2.81% | 6 |
|
|
2016
Q1 | $6.07M | Buy |
106,188
+1,959
| +2% | +$109K | 2.64% | 6 |
|
|
2015
Q4 | $6.17M | Buy |
104,229
+502
| +0.5% | +$28.9K | 2.89% | 5 |
|
|
2015
Q3 | $5.64M | Sell |
103,727
-222
| -0.2% | -$14.5K | 2.84% | 5 |
|
|
2015
Q2 | $6.98M | Sell |
103,949
-428
| -0.4% | -$27.9K | 3.3% | 3 |
|
|
2015
Q1 | $6.11M | Buy |
104,377
+1,205
| +1% | +$72.8K | 2.99% | 6 |
|
|
2014
Q4 | $6.75M | Sell |
103,172
-793
| -0.8% | -$50K | 3.37% | 3 |
|
|
2014
Q3 | $6M | Sell |
103,965
-505
| -0.5% | -$28K | 3.13% | 5 |
|
|
2014
Q2 | $5.9M | Sell |
104,470
-170
| -0.2% | -$8.92K | 2.92% | 5 |
|
|
2014
Q1 | $5.38M | Sell |
104,640
-50
| -0% | -$2.53K | 2.59% | 5 |
|
|
2013
Q4 | $5.53M | Sell |
104,690
-950
| -0.9% | -$46.7K | 2.74% | 5 |
|
|
2013
Q3 | $4.72M | Sell |
105,640
-3,250
| -3% | -$144K | 2.59% | 5 |
|
|
2013
Q2 | $4.5M | Buy |
+108,890
| New | +$4.76M | 2.68% | 6 |
|
Other funds holding ABBV
VCM
VPM
Rodgers Brothers's ABBV Position: Q1 2026 in Review
Rodgers Brothers increased its AbbVie (ABBV) stake by 0.39% in Q1 2026, buying an estimated $109K and bringing the position to 127,462 shares worth $27.7M. The position accounts for 3.2% of the portfolio, ranked #3.
Rodgers Brothers first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $29.9M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Rodgers Brothers held 127,462 shares of AbbVie worth $27.7M as of Q1 2026.
- Rodgers Brothers bought 490 AbbVie shares in Q1 2026, an estimated $109K.
- AbbVie made up 3.2% of Rodgers Brothers's portfolio in Q1 2026, its #3 holding.
- Rodgers Brothers first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Rodgers Brothers's AbbVie position peaked at $29.9M in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Rodgers Brothers's 13F filing for Q1 2026, filed 14 May 2026.